Travis Helm
Chief Operating Officer at Tremeau Pharmaceuticals, Inc.
Network origin in Travis Helm first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Travis Helm via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Thomas Jefferson University | College/University | Undergraduate Degree | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
| SIRONA BIOCHEM CORP. | Pharmaceuticals: Major | Director/Board Member | |
Franz Haniel & Cie. GmbH
 Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany. | Investment Managers | Private Equity Analyst | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lehigh University | College/University | Masters Business Admin | |
| Towson University | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Graduate Degree | |
| Friedrich Schiller University of Jena | College/University | Undergraduate Degree | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | ||
Crossover Health, Inc.
 Crossover Health, Inc. Medical/Nursing ServicesHealth Services Crossover Health, Inc. provides worksite health and wellness services. It offers primary, ancillary, and advanced services, includes urgent care, occupational health, preventive care, chronic disease management, health risk assessment, health education, health coaching, biometrics, physical therapy, chiropractic, acupuncture, specialist preferred network, care coordination, health analytics, and remote care. The company was founded by Scott Shreeve in 2010 and is headquartered in Aliso Viejo, CA. | Medical/Nursing Services | Director/Board Member | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lennham Pharmaceuticals, Inc.
 Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Pharmaceuticals: Major | Chief Executive Officer | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Biotechnology | Director/Board Member | |
| EQT Life Sciences (Munich) | Investment Managers | Consultant / Advisor | |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst |
Statistics
International
| United States | 17 |
| Germany | 5 |
| Canada | 3 |
| Netherlands | 2 |
Sectoral
| Health Technology | 12 |
| Consumer Services | 6 |
| Finance | 5 |
| Health Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 16 |
| Corporate Officer/Principal | 5 |
| Private Equity Investor | 5 |
| Undergraduate Degree | 4 |
| Chief Executive Officer | 3 |
Most connected contacts
| Insiders | |
|---|---|
| David S. Moore | 13 |
| Travis Wilson | 9 |
| Christoph Broja | 7 |
| Bradford C. Sippy | 2 |
| Chris Fanale | 1 |
| James Singleton | 1 |
- Stock Market
- Insiders
- Travis Helm
- Company connections
